icon-folder.gif   Conference Reports for NATAP  
 
  EASL - The International Liver Congress 2015
50th Annual Meeting of the European
Association for the Study of the Liver
Vienna, Austria  April 22-26
Back grey_arrow_rt.gif
 
 
 
All Oral HCV Therapy is Safe and Effective in Patients with Decompensated Cirrhosis: Report from HCV-TARGET
 
 
  Reported by Jules Levin
EASL 2015 April 22-26 Vienna Austria
 
K. Rajender Reddy, Joseph K. Lim, Alexander Kuo,
Adrian M. Di Bisceglie, Hugo E. Vargas, Joseph S. Galati, Giuseppe Morelli, Gregory T. Everson, Paul Kwo, Robert S. Brown, Mark S. Sulkowski, Lucy Akushevich, Thomas G. Stewart, Monika Vainorius, Joy A. Peter, David Nelson, Michael W. Fried, Michael P. Manns for the HCV-TARGET Study Group

EASL1.gif

EASL2.gif

EASL3.gif

EASL4.gif

EASL5.gif

EASL6.gif

EASL7.gif

EASL8.gif

EASL9.gif

EASL10.gif

EASL11.gif